Growth Factor Delivery is a critical aspect of regenerative medicine and tissue engineering, aiming to harness the therapeutic potential of growth factors for promoting tissue repair, regeneration, and healing. Growth factors are signalling molecules that regulate various cellular processes, including cell proliferation, differentiation, migration, and survival, making them potent mediators of tissue development and repair. Biomaterial-based delivery systems can be engineered to control the release kinetics of growth factors, allowing for precise modulation of their bioavailability and activity within the target tissue. By tuning parameters such as material composition, structure, porosity, and degradation rate, researchers can design delivery systems that release growth factors in response to specific physiological cues. Another strategy for growth factor delivery involves the use of gene therapy techniques to introduce genes encoding growth factors directly into target cells or tissues. This approach allows for sustained production and secretion of growth factors by genetically modified cells, offering prolonged and localized delivery without the need for exogenous protein administration. Furthermore, growth factor delivery can be enhanced through the use of cell-based delivery systems, where growth factor-secreting cells, such as stem cells, fibroblasts, or genetically engineered cells, are implanted or injected into the target tissue. These cells can continuously produce and release growth factors in response to local micro environmental cues, promoting tissue regeneration and repair.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy